Inhibition of the non-receptor tyrosine kinase ITK, a component of the T-cell receptor signalling cascade, may represent a novel treatment for allergic asthma. Here we report the structure-based optimization of a series of benzothiazole amides that demonstrate sub-nanomolar inhibitory potency against ITK with good cellular activity and kinase selectivity. We also elucidate the binding mode of these inhibitors by solving the X-ray crystal structures of several inhibitor-ITK complexes.
Keywords: Anti-inflammatory; Asthma; Benzothiazole; ITK inhibitor; SAR; TCR signalling.
Copyright © 2013 Elsevier Ltd. All rights reserved.